NCT06933277View on ClinicalTrials.gov

Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients

RecruitingOBSERVATIONAL

Enrollment

159

Participants

Timeline

Start Date

August 29, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions

Multiple Myeloma

Trial Locations (1)

Unknown

RECRUITING

Aou Careggi - Sod Ematologia, Florence

All Listed Sponsors

lead

Gruppo Italiano Malattie EMatologiche dell'Adulto

OTHER